Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (484)

Latest Posts

About This Stock More About This Stock
Pick These 4 Stocks With Exciting Interest Coverage Ratio
Article By: Zacks Investment Research
Saturday, November 26, 2022 8:13 PM EST
Let's take a look at some of the companies that boast an impressive interest coverage ratio.
In this article: GIS, GILD, ORLY, TXRH
Healthcare & Biotech Stocks: A Big Opportunity In 2023
Article By: Taki Tsaklanos
Sunday, October 30, 2022 5:55 PM EST
One of the areas that will come with opportunities for stock market investors in 2023 is the health care sector. This includes pharma, medical devices, biotech, and the likes.
In this article: GILD
Australia's Central Bank Has Raised Its Interest Rate. Business Activity In Europe Is Falling
Article By: JustMarkets
Tuesday, August 2, 2022 6:07 AM EST
Australia's Central Bank raised its interest rate by 50 basis points to 1.85%. The Bank said in a statement that it attaches great importance to getting inflation back into the 2-3 percent range over time while keeping the economy stable.
Daily Stock Analysis: Gilead Sciences, Inc.
Article By: Fredrik Arnold
Monday, July 18, 2022 4:00 AM EST
Gilead Sciences Inc shows a possible 13.87% net gain including a 4.66% forward-looking dividend yield. 
In this article: GILD
There Are Some Serious Deals In The Market Right Now
Video By: Jason Fieber
Saturday, June 11, 2022 2:40 PM EST
Interested in buying high-quality dividend growth stocks on sale? Want to know my top five stocks for June 2022? Then you have to check out this video.
In this video: BK, LOW, UPS, GILD, QCOM

Latest Tweets for $GILD

No tweets yet!



Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments